LFCR vs ROST · rev $75.5M vs P/E 21, rev $22.75B
Lifecore Biomedical Inc. (LFCR) versus Ross Stores Inc (ROST) — a side-by-side from cached financials, not a winner call.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Ross Stores Inc (ROST) is a apparel retail company listed on US.
Latest reported LFCR revenue for 2025-12-31 was $75.5M. Net income was -$18.0M. Revenue was up 771.6% from 2025-06-30 to 2025-12-31. LFCR currently screens at market cap $207.1M.
Latest reported ROST revenue for 2026-01-31 was $22.75B. Net income was $2.15B. Revenue was up 7.7% from 2025-02-01 to 2026-01-31. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
LFCR currently screens at market cap $207.1M. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
Not investment advice. Open the LFCR and ROST stock pages for the full models.
Not investment advice.